Literature DB >> 31120791

Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.

Jingbiao Chen1, Jing Zhou2, Sichi Kuang1, Yao Zhang1, Sidong Xie1, Bingjun He1, Ying Deng1, Hao Yang1, Qungang Shan1, Jun Wu1, Claude B Sirlin3, Jin Wang1.   

Abstract

OBJECTIVE. We investigated in Liver Imaging Reporting and Data System category 5 (LR-5) observations whether imaging features, including LI-RADS imaging features, could predict microvascular invasion (MVI) and posthepatectomy recurrence in high-risk adult patients with hepatocellular carcinoma (HCC). MATERIALS AND METHODS. We retrospectively identified 149 high-risk patients who underwent 3-T MRI within 1 month before hepatectomy for HCC; 81 of 149 patients with no HCC recurrence were followed for more than 1 year. Tumors with clear surgical margins were confirmed in each hepatectomy specimen. MVI was evaluated histologically by a histopathologist. Tumor recurrence was determined by clinical and imaging follow-up. Two independent radiologists reviewed the prehepatectomy MR images and assessed LI-RADS v2018 imaging features as well as some non-LI-RADS features in all LR-5 observations in consensus. Alpha-fetoprotein level, tumor number, and imaging features were analyzed as potential predictors for MVI and posthepatectomy recurrence using multivariate logistic regression and Cox proportional hazards models. RESULTS. One hundred forty-nine patients with pathologically confirmed HCC were included; 64 of 149 (43.0%) patients had MVI, whereas 48 of 129 (37.2%) patients had tumor recurrence within 3 years after hepatectomy. Mosaic architecture (odds ratio, 3.420; p < 0.001) and nonsmooth tumor margin (odds ratio, 2.554; p = 0.011) were independent predictors of MVI. Multifocal tumors (hazard ratio, 2.101; p = 0.034), absence of fat in mass (hazard ratio, 2.109; p = 0.015), and nonsmooth tumor margin (hazard ratio, 2.415; p = 0.005) were independent predictors of posthepatectomy recurrence. CONCLUSION. In high-risk patients with LR-5 HCC, mosaic architecture and non-smooth tumor margin independently predicted MVI. Multifocal tumors, absence of fat in mass, and nonsmooth tumor margin independently predicted recurrence.

Entities:  

Keywords:  Liver Imaging Reporting and Data System; MRI; hepatocellular carcinoma; microvascular invasion; recurrence

Year:  2019        PMID: 31120791     DOI: 10.2214/AJR.19.21168

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

1.  Prediction of early recurrence of hepatocellular carcinoma after resection based on Gd-EOB-DTPA enhanced magnetic resonance imaging: a preliminary study.

Authors:  Qi-Yu Zhao; Shi-Shun Liu; Ming-Xin Fan
Journal:  J Gastrointest Oncol       Date:  2022-04

2.  Contrast-enhanced ultrasound-based ultrasomics score: a potential biomarker for predicting early recurrence of hepatocellular carcinoma after resection or ablation.

Authors:  Hui Huang; Si-Min Ruan; Meng-Fei Xian; Ming-de Li; Mei-Qing Cheng; Wei Li; Yang Huang; Xiao-Yan Xie; Ming-de Lu; Ming Kuang; Wei Wang; Hang-Tong Hu; Li-Da Chen
Journal:  Br J Radiol       Date:  2021-11-29       Impact factor: 3.039

3.  Preoperative estimation of the survival of patients with unresectable hepatocellular carcinoma achieving complete response after conventional transcatheter arterial chemoembolization: assessments of clinical and LI-RADS MR features.

Authors:  Wenlong Song; Qianyu Chen; Dajing Guo; Caiming Jiang
Journal:  Radiol Med       Date:  2022-08-26       Impact factor: 6.313

4.  Evaluation of perfusion CT and dual-energy CT for predicting microvascular invasion of hepatocellular carcinoma.

Authors:  Maïté Lewin; Astrid Laurent-Bellue; Christophe Desterke; Adina Radu; Joëlle Ann Feghali; Jad Farah; Hélène Agostini; Jean-Charles Nault; Eric Vibert; Catherine Guettier
Journal:  Abdom Radiol (NY)       Date:  2022-04-13

5.  Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.

Authors:  Lin Sun; Luwen Mu; Jing Zhou; Wenjie Tang; Linqi Zhang; Sidong Xie; Jingbiao Chen; Jin Wang
Journal:  Cancer Immunol Immunother       Date:  2021-05-16       Impact factor: 6.968

6.  A Radiomics Nomogram for Preoperative Prediction of Early Recurrence of Small Hepatocellular Carcinoma After Surgical Resection or Radiofrequency Ablation.

Authors:  Liting Wen; Shuping Weng; Chuan Yan; Rongping Ye; Yuemin Zhu; Lili Zhou; Lanmei Gao; Yueming Li
Journal:  Front Oncol       Date:  2021-04-29       Impact factor: 6.244

7.  The Role of Preoperative Dynamic Contrast-enhanced 3.0-T MR Imaging in Predicting Early Recurrence in Patients With Early-Stage Hepatocellular Carcinomas After Curative Resection.

Authors:  Linqi Zhang; Sichi Kuang; Jingbiao Chen; Yao Zhang; Binliang Zhao; Hao Peng; Yuanqiang Xiao; Kathryn Fowler; Jin Wang; Claude B Sirlin
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

8.  Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival.

Authors:  Lidi Ma; Kan Deng; Cheng Zhang; Haixia Li; Yingwei Luo; Yingsi Yang; Congrui Li; Xinming Li; Zhijun Geng; Chuanmiao Xie
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

9.  An excellent nomogram predicts microvascular invasion that cannot independently stratify outcomes of small hepatocellular carcinoma.

Authors:  Huanhuan Chong; Peiyun Zhou; Chun Yang; Mengsu Zeng
Journal:  Ann Transl Med       Date:  2021-05

10.  Value of gadoxetic acid-enhanced MRI for microvascular invasion of small hepatocellular carcinoma: a retrospective study.

Authors:  Meng Zhou; Dan Shan; Chunhui Zhang; Jianhua Nie; Guangyu Wang; Yanqiao Zhang; Yang Zhou; Tongsen Zheng
Journal:  BMC Med Imaging       Date:  2021-03-05       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.